Friday, August 9, 2013

TP53 Mutations and Breast Cancer Prognosis

TP53 Mutations and Breast Cancer Prognosis

Nicknamed the "guardian of the genome," TP53 determines if a cell is too damaged to be repaired and must therefore undergo cell death (apoptosis). Mutations in TP53 are the most common mutation found in cancers. Mutation means that the ability to "guard the genome" is lost, and therefore the fate of the cell is no longer controlled, and damaged cells can continue to divide.

Breast Cancer

    Breast cancer is not a single disease, as several varieties exist. However, breast cancer is the most common cancer diagnosed in women.

Prognostic Markers

    Prognostic markers are important in determining what treatment is required. A number of prognostic markers have been determined for breast cancer: a person's age and whether she is still having periods, the size of the tumor, if cancer is in the lymph nodes, if the cancer has spread to other organs, the type of cancer, how different it is from normal tissue (tissue grade) and the expression of certain proteins on the tumor cells (hormone receptor expression).

TP53 and Prognosis

    Over half of all breast cancers show a mutated TP53 gene. Mutations in TP53 have been linked with a poor prognosis in breast cancer independent of other prognostic markers. However, a number of different mutations in TP53 have been found in breast cancer, and these different mutations can also influence prognosis.

Detecting Mutations

    TP53 mutations can only be detected in the laboratory on tissue taken from cancer cells. Either the protein (which detects some mutations) is studied, or the whole gene (which detects all mutations) is examined.

TP53 and Chemotherapy

    Mutated TP53 can also affect the response that the breast cancer has to chemotherapy treatment. In the future, treatment options may depend on the presence and type of TP53 mutations found in the cancer.



  • BRCA1 & BRCA2: Cancer Risk & Genetic Testing - National Cancer ...

    www.cancer.gov/cancertopics/factsheet/Risk/BRCA

    Key Points. BRCA1 and BRCA2 are human genes that belong to a class of genes known as tumor suppressors. Mutation of these genes has been linked to hereditary breast ...


  • Breast cancer - Wikipedia, the free encyclopedia

    en.wikipedia.org/wiki/Breast_cancer

    Breast cancer is a type of cancer originating from breast tissue, most commonly from the inner lining of milk ducts or the lobules that supply the ducts with milk.


  • Triple Negative Breast Cancer what do we know and where are

    ww5.komen.org/Content.aspx?id=19327354168

    Although breast cancer is often referred to as one disease, there are actually many different types of breast cancer. The differences can help guide treatment and ...

  • UT MD Anderson Study Finds Women with Both Triple Negative Breast ...

    www.mdanderson.org Newsroom MDAndersonNewsReleases

    Patients with triple negative breast cancer that also have mutations in the BRCA gene appear to have a lower risk of recurrence, compared to those with the same ...


  • JAMA Network JAMA Race, Breast Cancer Subtypes, and Survival ...

    jama.jamanetwork.com/article.aspx?articleid=202952

    Race, Breast Cancer Subtypes, and Survival in the Carolina Breast Cancer Study FREE


  • BRCA1 and BRCA2 Genetic Mutations and Cancer Risk: Johns

    www.hopkinsmedicine.org Breast Cancers & Other Conditions

    The Johns Hopkins Breast Center in Baltimore, MD, offers screening for the BRCA1 or BRCA2 genetic mutation and provides preventive services for women who test ...


  • TP53 Gene - GeneCards P53 Protein P53 Antibody

    www.genecards.org/cgi-bin/carddisp.pl?gene=TP53

    Complete information for TP53 gene (protein-coding), tumor protein p53


  • Sequence analysis of mutations and translocations across breast ...

    www.ncbi.nlm.nih.gov/pubmed/22722202

    1. Nature. 2012 Jun 20;486(7403):405-9. doi: 10.1038/nature11154. Sequence analysis of mutations and translocations across breast cancer subtypes.


  • JAMA Network JAMA Spectrum of Mutations in BRCA1,

    jama.jamanetwork.com/article.aspx?articleid=202583

    Spectrum of Mutations in BRCA1, BRCA2, CHEK2, and TP53 in Families at High Risk of Breast Cancer FREE


  • NCI Cancer Bulletin for February 9, 2010 - National Cancer Institute

    www.cancer.gov/aboutnci/ncicancerbulletin/archive/2010/020910/page3

    NCI's biweekly online newsletter provides useful, timely information about cancer research to the cancer community.


  • Cancer - Wikipedia, the free encyclopedia

    en.wikipedia.org/wiki/Cancer

    Cancer i known medically as a malignant neoplasm, is a broad group of various diseases, all involving unregulated cell growth. In cancer, cells divide and grow ...


  • Breast Cancer

    emedicine.medscape.com/article/1947145-overview

    Jun 17, 2013 Breast Cancer. Worldwide, breast cancer is the most frequently diagnosed life-threatening cancer in women and the leading cause of cancer death in

  • BRCA Genetic Testing for Patients With and Without Breast Cancer

    https://www.breastsurgeons.org/statements/PDF_Statements/BRCA... PDF file

    Position Statement on BRCA Genetic Testing for Patients With and Without Breast Cancer Introduction Of the more than 200,000 breast cancers diagnosed annually in

  • Cancer Diagnostics and Testing, Molecular Diagnostics Reference ...

    www.clarientinc.com

    Clarient is a cancer diagnostics company molecular diagnostics services to pathologists and oncologists. Clarient provides testing on PI3K, EML4-ALK, BRAF, KRAS, EGFR ...


  • Whole-genome analysis informs breast cancer response to

    www.nature.com/nature/journal/v486/n7403/full/nature11143.html

    Abstract Introduction Results Significantly mutated genes in luminal breast cancer Correlating mutations with clinical data Structural variation ...


  • Breast Cancer Research Full text The gene expression

    breast-cancer-research.com/content/14/4/R113

    Gene expression data derived from clinical cancer specimens provide an opportunity to characterize cancer-specific transcriptional programs. Here, we present an ...


  • Human Breast Cancer GeneRead DNAseq Gene Panel

    www.sabiosciences.com/NGS_product/HTML/NGHS-001Z.html

    Human Breast Cancer GeneRead DNAseq Gene Panel: The Human Breast Cancer GeneRead DNAseq Gene Panel is a multiplexed PCR based assay for targeted

  • Breast Cancer Research

    breast-cancer-research.com

    Online and print journal covering topics of basic and clinical research relevant to breast cancer. Research articles are free to all users.

  • Breast cancer genes : Cancer Research UK : CancerHelp UK

    www.cancerresearchuk.org/cancer-help/type/breast-cancer/about/...

    This page is about inherited faulty genes that can increase the risk of breast cancer.

  • Breast Cancer: Laboratory Support of Diagnosis and Management

    www.questdiagnostics.com/.../testguide.action?dc=CF_Breast_Cancer

    Clinical Background [return to contents] Invasive breast cancer is the most frequently diagnosed cancer in women in the United States and is second to lung cancer as ...

  • Recurrence of Breast Cancer

    recurrence-of.breastcancer.co

    Recurring breast cancer, also referred to as recurrent breast cancer, is breast cancer that comes back after a length of time during which it could no longer be ...

  • Breast cancer - SNPedia

    www.snpedia.com/index.php/Breast_cancer

    Wikipedia provides a good introduction to breast cancer. Advice from the National Cancer Institute In general, the mutations that are recognized to increase breast ...

  • K-ras Mutations and Benefit from Cetuximab in Advanced

    www.nejm.org/doi/full/10.1056/NEJMoa0804385

    Original Article from The New England Journal of Medicine K-ras Mutations and Benefit from Cetuximab in Advanced Colorectal Cancer

  • TP53 tumor protein p53 [Homo sapiens (human)]

    www.ncbi.nlm.nih.gov/gene/7157

    This gene encodes a tumor suppressor protein containing transcriptional activation, DNA binding, and oligomerization domains. The encoded protein responds to diverse ...

0 comments:

Post a Comment